AbCellera (ABCL)
5.09
-0.21 (3.96%)
Upcoming Events
Latest Headlines
Form 8-K AbCellera Biologics Inc. For: Jun 01
June 5, 2026 12:04 PM - SEC Filing
AbCellera appoints Dr. Victor Sandor to board of directors
June 5, 2026 9:00 AM - StreetInsider
AbCellera Appoints Dr. Victor Sandor to its Board of Directors
June 5, 2026 9:00 AM - BizWire
Form 4 AbCellera Biologics Inc. For: Jun 03 Filed by: Booth Andrew
June 3, 2026 2:23 PM - SEC Filing
AbCellera Biologics (ABCL) PT Raised to $12 at Truist Securities
May 22, 2026 7:05 AM - StreetInsider
Increasing unusual put option volume: TIGR XLI EXE INFQ ABCL FUTU INTU CMPS ADMA
May 21, 2026 9:57 AM - StreetInsider
Form 4 AbCellera Biologics Inc. For: May 14 Filed by: Montalbano John S.
May 18, 2026 12:10 PM - SEC Filing
AbCellera Biologics (ABCL) PT Raised to $11 at Cantor Fitzgerald Post Q1 Print, Trial Data
May 12, 2026 8:50 AM - StreetInsider
AbCellera Biologics (ABCL) PT Raised to $8 at Stifel on Positive Data for ABCL635
May 12, 2026 7:27 AM - StreetInsider
AbCellera Biologics (ABCL) PT Raised to $13 at Jones Trading
May 12, 2026 7:09 AM - StreetInsider
Form 10-Q AbCellera Biologics Inc. For: Mar 31
May 11, 2026 4:19 PM - SEC Filing
Form 8-K AbCellera Biologics Inc. For: May 11
May 11, 2026 4:12 PM - SEC Filing
AbCellera (ABCL) Tops Q1 EPS by 1c
May 11, 2026 4:06 PM - StreetInsider
AbCellera reports positive phase 1 data for menopause drug ABCL635
May 11, 2026 4:05 PM - StreetInsider
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
May 11, 2026 4:05 PM - BizWire
Form SCHEDULE 13G/A AbCellera Biologics Inc. Filed by: BAKER BROS. ADVISORS LP
May 7, 2026 4:13 PM - SEC Filing
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
May 7, 2026 4:05 PM - BizWire
Cantor Fitzgerald Starts AbCellera Biologics (ABCL) at Overweight
May 5, 2026 6:08 AM - StreetInsider
Form ARS AbCellera Biologics Inc. For: Dec 31
April 29, 2026 3:09 PM - SEC Filing
Form DEFA14A AbCellera Biologics Inc.
April 29, 2026 2:10 PM - SEC Filing
Form DEF 14A AbCellera Biologics Inc. For: Dec 31
April 29, 2026 2:07 PM - SEC Filing
AbCellera to share phase 1 data for menopause treatment during earnings
April 20, 2026 9:00 AM - StreetInsider
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call
April 20, 2026 9:00 AM - BizWire
Truist Securities Reiterates Buy Rating on AbCellera Biologics (ABCL)
April 15, 2026 10:01 AM - StreetInsider
Truist Securities Reiterates Buy Rating on AbCellera Biologics (ABCL)
April 15, 2026 10:01 AM - StreetInsider
Jones Trading Starts AbCellera Biologics (ABCL) at Buy
April 9, 2026 4:08 PM - StreetInsider
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
April 1, 2026 4:05 PM - BizWire
Full Article List
